tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
Advertisement

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
425 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is 0.52, suggesting TransCode Therapeutics is a Buy.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 10.82, while TransCode Therapeutics’s (RNAZ) share price is $11.59, making it a Buy.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 12.23, while TransCode Therapeutics’s (RNAZ) share price is $11.59, making it a Sell.

TransCode Therapeutics (RNAZ) Pivot Points

Aug 14, 2025, 11:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.27
10.52
11.01
11.26
11.75
12.00
12.49
Fibonacci
10.52
10.80
10.98
11.26
11.54
11.72
12.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Aug 14, 2025, 11:19 PM
Period
Simple
Exponential
MA5
11.02Buy
11.27Buy
MA10
11.17Buy
11.17Buy
MA20
11.08Buy
10.82Buy
MA50
9.16Buy
12.23Sell
MA100
10.20Buy
36.78Sell
MA200
113.09Sell
130.43Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 11.17, while TransCode Therapeutics’s (RNAZ) share price is $11.59, making it a Buy.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 36.78, while TransCode Therapeutics’s (RNAZ) share price is $11.59, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $11.59 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 9.16, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $11.59 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 10.20, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $11.59 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 113.09, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Aug 14, 2025, 11:19 PM
Name
Value
Implied Action
RSI (14)
57.66
Neutral
STOCH (9,6)
58.25
Neutral
STOCHRSI (14)
20.05
Neutral
MACD (12,26)
0.52
Buy
ADX (14)
44.81
Neutral
Williams %R
-75.00
Buy
CCI (14)
8.65
Neutral
ATR (14)
1.26
-
Ultimate Oscillator
52.08
Neutral
ROC
5.36
Buy
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 57.66, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 44.81, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is 8.65, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is 5.36, creating a Buy signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Buy.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 57.66, which suggests RNAZ is a Neutral.
      What is RNAZ’s MACD?
      RNAZ’s MACD is 0.52, which suggests RNAZ is a Buy.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 11.02, which suggests RNAZ is a Buy.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 11.08, which suggests RNAZ is a Buy.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 9.16, which suggests RNAZ is a Buy.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 113.09, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -75.00, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is 8.65, which suggests RNAZ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis